Latest Insider Transactions at Lantheus Holdings, Inc. (LNTH)
This section provides a real-time view of insider transactions for Lantheus Holdings, Inc. (LNTH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Lantheus Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Lantheus Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 15
2023
|
Andrea Sabens Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
385
-0.62%
|
$38,115
$99.36 P/Share
|
May 11
2023
|
Brian A Markison CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,012
+8.62%
|
-
|
May 11
2023
|
Julie Mc Hugh Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,012
+6.6%
|
-
|
May 11
2023
|
Heinz Christoph Maeusli Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,012
+6.51%
|
-
|
May 11
2023
|
Minnie Baylor Henry Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,012
+29.94%
|
-
|
May 11
2023
|
Sam R Leno Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,012
+3.36%
|
-
|
May 11
2023
|
Daniel Niedzwiecki Officer |
SELL
Open market or private sale
|
Direct |
6,113
-7.82%
|
$599,074
$98.82 P/Share
|
May 11
2023
|
Gerard Ber Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,012
+5.48%
|
-
|
May 11
2023
|
James H Thrall Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,012
+5.82%
|
-
|
May 11
2023
|
Gary J Pruden Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,012
+5.75%
|
-
|
May 08
2023
|
Gerard Ber Director |
SELL
Payment of exercise price or tax liability
|
Direct |
327
-0.88%
|
$30,738
$94.82 P/Share
|
Apr 17
2023
|
Etienne Montagut Chief Business Officer |
SELL
Open market or private sale
|
Direct |
2,118
-3.05%
|
$186,384
$88.67 P/Share
|
Apr 17
2023
|
Daniel Niedzwiecki Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,301
+4.05%
|
-
|
Apr 17
2023
|
Andrea Sabens Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
386
-0.62%
|
$33,968
$88.67 P/Share
|
Apr 17
2023
|
Paul Blanchfield President |
BUY
Grant, award, or other acquisition
|
Direct |
8,464
+8.18%
|
-
|
Apr 03
2023
|
Etienne Montagut Chief Business Officer |
SELL
Open market or private sale
|
Direct |
3,684
-5.04%
|
$302,088
$82.09 P/Share
|
Mar 27
2023
|
Etienne Montagut Chief Business Officer |
SELL
Open market or private sale
|
Direct |
14,528
-16.59%
|
$1,176,768
$81.13 P/Share
|
Mar 27
2023
|
Mary Anne Heino Director |
SELL
Open market or private sale
|
Indirect |
44,484
-4.91%
|
$3,558,720
$80.89 P/Share
|
Mar 27
2023
|
Mary Anne Heino Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
44,484
+8.75%
|
$845,196
$19.11 P/Share
|
Mar 27
2023
|
Brian A Markison CEO |
SELL
Open market or private sale
|
Direct |
13,290
-40.76%
|
$1,076,490
$81.13 P/Share
|
Mar 27
2023
|
Sam R Leno Director |
SELL
Open market or private sale
|
Direct |
7,012
-5.72%
|
$560,960
$80.89 P/Share
|
Mar 27
2023
|
Sam R Leno Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,012
+10.02%
|
$133,228
$19.11 P/Share
|
Mar 15
2023
|
Robert J. Marshall Jr. CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
5,000
-3.75%
|
$355,000
$71.58 P/Share
|
Mar 15
2023
|
Andrea Sabens Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
386
-0.62%
|
$27,406
$71.58 P/Share
|
Mar 08
2023
|
Mary Anne Heino Director |
SELL
Open market or private sale
|
Direct |
10,064
-0.69%
|
$744,736
$74.74 P/Share
|
Mar 07
2023
|
Daniel Niedzwiecki Officer |
SELL
Open market or private sale
|
Direct |
1,055
-1.39%
|
$75,960
$72.15 P/Share
|
Mar 07
2023
|
Etienne Montagut Chief Business Officer |
SELL
Open market or private sale
|
Direct |
3,531
-3.89%
|
$254,232
$72.15 P/Share
|
Mar 07
2023
|
Robert J. Marshall Jr. CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
4,854
-3.51%
|
$349,488
$72.15 P/Share
|
Mar 07
2023
|
Paul Blanchfield President |
SELL
Open market or private sale
|
Direct |
2,758
-3.1%
|
$198,576
$72.15 P/Share
|
Mar 07
2023
|
Andrea Sabens Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
950
-1.49%
|
$68,400
$72.15 P/Share
|
Mar 06
2023
|
Daniel Niedzwiecki Officer |
SELL
Open market or private sale
|
Direct |
9,079
-10.68%
|
$653,688
$72.56 P/Share
|
Mar 06
2023
|
Etienne Montagut Chief Business Officer |
SELL
Open market or private sale
|
Direct |
14,179
-13.5%
|
$1,020,888
$72.56 P/Share
|
Mar 06
2023
|
Robert J. Marshall Jr. CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
20,587
-12.97%
|
$1,482,264
$72.56 P/Share
|
Mar 06
2023
|
Paul Blanchfield President |
SELL
Open market or private sale
|
Direct |
5,250
-5.56%
|
$378,000
$72.56 P/Share
|
Mar 06
2023
|
Andrea Sabens Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
7,705
-10.8%
|
$554,760
$72.56 P/Share
|
Mar 06
2023
|
Mary Anne Heino Director |
SELL
Open market or private sale
|
Direct |
12,189
-1.64%
|
$889,797
$73.24 P/Share
|
Mar 03
2023
|
Robert J. Marshall Jr. CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
17,391
+9.87%
|
-
|
Mar 03
2023
|
Daniel Niedzwiecki Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,515
+8.12%
|
-
|
Mar 03
2023
|
Etienne Montagut Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,361
+10.53%
|
-
|
Mar 03
2023
|
Mary Anne Heino Director |
SELL
Open market or private sale
|
Direct |
82,055
-5.07%
|
$5,990,015
$73.13 P/Share
|
Mar 03
2023
|
Mary Anne Heino Director |
BUY
Grant, award, or other acquisition
|
Direct |
74,486
+8.29%
|
-
|
Mar 03
2023
|
Andrea Sabens Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,099
+9.05%
|
-
|
Mar 02
2023
|
Robert J. Marshall Jr. CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
20,283
+12.55%
|
-
|
Mar 02
2023
|
Paul Blanchfield President |
BUY
Grant, award, or other acquisition
|
Direct |
20,383
+17.77%
|
-
|
Mar 02
2023
|
Jean Claude Provost Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
16,359
+44.0%
|
-
|
Mar 02
2023
|
Etienne Montagut Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,968
+13.1%
|
-
|
Mar 02
2023
|
Mary Anne Heino Director |
BUY
Grant, award, or other acquisition
|
Direct |
76,686
+9.29%
|
-
|
Mar 02
2023
|
Andrea Sabens Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,772
+5.55%
|
-
|
Feb 15
2023
|
Andrea Sabens Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
386
-0.63%
|
$22,002
$57.52 P/Share
|
Jan 17
2023
|
Andrea Sabens Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
386
-0.63%
|
$20,072
$52.97 P/Share
|